CERo Therapeutics Inc. (CERO)

AI Score

Unlock

0.62

0.02 (3.85%)

At close: Apr 17, 2025, 3:59 PM

0.60

-3.28%

After-hours: Apr 17, 2025, 07:55 PM EDT

CERo Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Cash & Equivalents	3.33M	3.38M	3.65M	4.59M	96.87K	119.01K	105.23K	178.09K	42.14M	507.92K	553.77K	790.48K	1.1M	n/a	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	8.44M	8.33M	13.9M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	2.5M	n/a	n/a	n/a	14.03M	n/a	179.64M	178.79M	178.53M	178.5M	n/a	n/a
Other Long-Term Assets	500K	500K	550K	683.35K	n/a	n/a	n/a	-4M	n/a	21.18K	87.35K	152.79K	200.65K	277K	1K
Receivables	n/a	n/a	87.43K	162.06K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	386.98K	334.28K	511.46K	746.04K	8.44M	8.33M	13.9M	220.29K	225.19K	0.00	n/a	n/a	262.5K	24K	n/a
Total Current Assets	3.71M	3.71M	4.25M	5.5M	8.56M	8.47M	14.11M	398.39K	42.37M	785.29K	846.02K	1.1M	1.36M	24K	24K
Property-Plant & Equipment	1.99M	2.28M	2.57M	2.87M	n/a	n/a	n/a	4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.49M	2.78M	3.12M	6.05M	n/a	n/a	n/a	14.03M	n/a	179.67M	178.88M	178.68M	178.72M	277K	1K
Total Assets	6.21M	6.49M	7.37M	11.55M	8.56M	8.47M	14.11M	14.43M	42.37M	180.45M	179.72M	179.78M	180.08M	301K	25K
Account Payables	4.51M	6.67M	6.35M	7.06M	3.54K	3.31K	3.15K	868.86K	1.65K	710.35	n/a	n/a	n/a	n/a	1K
Deferred Revenue	n/a	-49.12K	n/a	-7.06K	20.1K	25.46K	63.57K	-269.7K	597.5K	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	876.39K	102.27K	253.17K	402.51K	1.55M	1.4M	1.18M	650K	650K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	2.02M	30K	200K	3.1M	3.51M	3.29M	3.09M	1.75M	29.5M	710.36K	163K	124.66K	n/a	277K	n/a
Total Current Liabilities	7.4M	9.42M	8.78M	11.65M	5.17M	4.8M	4.41M	3.29M	30.75M	875.97K	234.21K	174.66K	98.07K	277K	1K
Long-Term Debt	699.11K	n/a	n/a	n/a	n/a	n/a	n/a	2.16M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	13.72K	9.15M	9.15M	9.15M	6.99M	9.15M	9.15M	9.15M	9.15M	9.15M	n/a	n/a
Total Long-Term Liabilities	699.11K	771.52K	1.07M	1.38M	9.15M	9.15M	9.15M	9.15M	9.15M	9.15M	9.15M	9.15M	9.15M	n/a	n/a
Total Liabilities	8.1M	10.19M	9.85M	13.03M	14.32M	13.95M	13.56M	12.44M	39.9M	10.03M	9.38M	9.32M	9.25M	277K	1K
Total Debt	1.58M	1.8M	2.15M	2.56M	1.55M	1.4M	1.18M	650K	650K	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	85.74K	14.75K	2.27K	1.45K	8.44M	8.29M	13.84M	13.57M	13.22M	179.48M	178.5M	178.5M	178.5M	467.00	468.00
Retained Earnings	-70.92M	-71.59M	-67.36M	-64.91M	-14.2M	-13.77M	-13.29M	-11.58M	-10.76M	-9.06M	-8.16M	-8.05M	-7.67M	-1K	-1K
Comprehensive Income	n/a	n/a	-8.94M	-2.5K	0.00	n/a	n/a	0.00	n/a	n/a	n/a	n/a	n/a	n/a	-0.00
Shareholders Equity	-1.89M	-3.7M	-2.48M	-1.48M	-5.76M	-5.48M	549.25K	1.99M	2.47M	170.43M	170.34M	170.45M	170.83M	24K	24K
Total Investments	n/a	n/a	2.19M	2.5M	8.44M	8.33M	13.9M	14.03M	n/a	179.64M	178.79M	178.53M	178.5M	n/a	n/a